- Home
- SFHG vs RANI Comparison
SFHG vs RANI Comparison
Compare SFHG & RANI Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- SFHG
- RANI
- Stock Information
- Founded
- SFHG 1993
- RANI 2012
- Country
- SFHG Hong Kong
- RANI United States
- Employees
- SFHG N/A
- RANI N/A
- Industry
- SFHG Publishing
- RANI Medicinal Chemicals and Botanical Products
- Sector
- SFHG Consumer Discretionary
- RANI Health Care
- Exchange
- SFHG Nasdaq
- RANI Nasdaq
- Market Cap
- SFHG 16.2M
- RANI 17.0M
- IPO Year
- SFHG 2024
- RANI 2021
- Fundamental
- Price
- SFHG $0.78
- RANI $0.54
- Analyst Decision
- SFHG
- RANI Strong Buy
- Analyst Count
- SFHG 0
- RANI 4
- Target Price
- SFHG N/A
- RANI $7.75
- AVG Volume (30 Days)
- SFHG 49.7K
- RANI 323.8K
- Earning Date
- SFHG 07-15-2025
- RANI 08-05-2025
- Dividend Yield
- SFHG N/A
- RANI N/A
- EPS Growth
- SFHG N/A
- RANI N/A
- EPS
- SFHG N/A
- RANI N/A
- Revenue
- SFHG $19,760,935.00
- RANI $1,200,000.00
- Revenue This Year
- SFHG N/A
- RANI N/A
- Revenue Next Year
- SFHG N/A
- RANI N/A
- P/E Ratio
- SFHG N/A
- RANI N/A
- Revenue Growth
- SFHG 30.89
- RANI N/A
- 52 Week Low
- SFHG $0.55
- RANI $0.46
- 52 Week High
- SFHG $24.00
- RANI $4.19
- Technical
- Relative Strength Index (RSI)
- SFHG N/A
- RANI 42.19
- Support Level
- SFHG N/A
- RANI $0.50
- Resistance Level
- SFHG N/A
- RANI $0.60
- Average True Range (ATR)
- SFHG 0.00
- RANI 0.03
- MACD
- SFHG 0.00
- RANI 0.02
- Stochastic Oscillator
- SFHG 0.00
- RANI 42.04
About SFHG Samfine Creation Holdings Group Limited Ordinary Share
Samfine Creation Holdings Group Ltd operates through its subsidiaries. It is an established one-stop printing service provider which principally provides printing services in Hong Kong and the PRC. It offers a wide range of printed products such as (i) book products, which mainly include children's books, educational books, art books, notebooks, diaries and journals; and (ii) novelty and packaging products, which mainly include handcraft products, book sets, pop-up books, stationery products, products with assembly parts and other specialized products, shopping bags and package boxes.
About RANI Rani Therapeutics Holdings Inc.
Rani Therapeutics Holdings Inc is a clinical-stage biotherapeutics company advancing technologies to enable the development of orally administered biologics to provide patients, physicians, and healthcare systems with a convenient alternative to painful injections. The company has developed the RaniPill capsule, which is designed to deliver a wide variety of drug substances, including antibodies, proteins, peptides, and oligonucleotides. RaniPill is a proprietary and patented platform technology, intended to replace subcutaneous or IV injection of biologics with oral dosing. The company is also engaged in developing RaniPill HC, which is intended to enable the delivery of drug payloads in liquid form with high bioavailability.